Results 211 to 220 of about 246,416 (344)

Implementation of Network for the Improvement of Addiction Treatment (NIATx) Processes in Substance Use Disorder Treatment Centers

Journal of Behavioral Health Services & Research, 2016
D. Fields, H. Knudsen, P. Roman
semanticscholar   +1 more source

Associations between inclusive community coalition leadership and use of evidence‐based practices

American Journal of Community Psychology, EarlyView.
Abstract Community coalitions have the potential to elicit diverse participants' perspectives on complex issues and generate shared commitment to adaptive strategies. Ideally, these approaches have been found effective elsewhere. Despite evidence that leadership plays a generally important role in coalitions, there have been limited prior findings ...
Rebecca Wells, Nalini Ranjit, Louis D. Brown, Sarah M. Chilenski, Yvonne Mary Gaddy   +4 more
wiley   +1 more source

Recent incarceration and minoritized racial status as barriers to the effectiveness of recovery management checkups. [PDF]

Subst Abuse Treat Prev Policy
Kahn JH, Hart MK, Watson DP, Allen CB, Singh RR, Grella CE, Dennis ML.   +6 more
europepmc   +1 more source

Rural substance use treatment centers in the United States: an assessment of treatment quality by location

The American Journal of Drug and Alcohol Abuse, 2015
M. Edmond, L. Aletraris, P. Roman
semanticscholar   +1 more source

A Systematic Review of Adverse Childhood Experiences and Epigenetic Age Acceleration in Later Adult Life Measured With Second and Third‐Generation Epigenetic Clocks

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT We examined the relationship between adverse childhood experiences (ACEs) and epigenetic age acceleration (EAA) in adulthood as measured by second and third generation epigenetic clocks by performing a systematic review of the literature. The electronic databases MEDLINE and EMBASE were searched on 17 July 2023.
Matthew Green, Laura Horsfall, Azam Saied   +2 more
wiley   +1 more source

Tobacco-Related Knowledge Among Employees at Substance Use Treatment and Medical Healthcare Centers Serving Rural and Medically Underserved Patients with Substance Use Disorders in Texas, USA. [PDF]

Int J Environ Res Public Health
Feyisetan JA, Britton M, Chen TA, Martinez Leal I, Sekhar MS, Williams T, Casey K, Siddiqi AD, Reitzel LR.   +8 more
europepmc   +1 more source

Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT In Attention Deficit Hyperactivity Disorder (ADHD), methylphenidate is one of the most widely used drugs, in which patient response significantly impacts prognosis. This study aimed to characterize the molecular profile of 10 genes associated with methylphenidate therapy.
Aline Pasquini Santos, Tatiane Carinta de Souza, Kaio Evandro Cardoso Aguiar, Ana Caroline Alves da Costa, Natasha Monte, Juliana Carla Gomes Rodrigues, Giovanna Gilioli da Costa Nunes, Rita de Cássia Calderaro Coelho, Ândrea Ribeiro‐dos‐Santos, André Maurício Ribeiro dos Santos, Sandro José de Souza, Sidney Emanuel Batista dos Santos, Rommel Mario Rodriguez Burbano, Marianne Rodrigues Fernandes, Ney Pereira Carneiro dos Santos   +14 more
wiley   +1 more source

Risk Factors and Onset of Illicit Drug Use among Filipino Youth: A Cross-sectional Analysis of Sociodemographic and Environmental Influences. [PDF]

Acta Med Philipp
Baula EU, Salvador KRB, Ramiro LS, Martinez AB, Miranda GMJ, Estacio JZD, Alibudbud RC, Estacio LR.   +7 more
europepmc   +1 more source

Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment

Substance Abuse, 2015
Maria Paino, L. Aletraris, P. Roman
semanticscholar   +1 more source

Schizophrenia Genetics Modulates Clinical Depressive Features

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, EarlyView.
ABSTRACT Schizophrenia (SCZ) genetic liability, quantified by polygenic scores (PGS), may influence clinical phenotypes in major depressive disorder (MDD). We investigated the effect of the SCZ‐PGS derived from the latest SCZ genome‐wide association study (GWAS) on MDD symptom severity, comorbidities, and treatment outcomes.
Alessandro Serretti, Daniel Souery, Siegfried Kasper, Joseph Zohar, Stuart Montgomery, Panagiotis Ferentinos, Dan Rujescu, Raffaele Ferri, Giuseppe Fanelli, Chiara Fabbri, Raffaella Zanardi, Francesco Benedetti, Bernhard T. Baune, Julien Mendlewicz   +13 more
wiley   +1 more source